Physician’s Weekly (April 15) – Dr. Timothy Fan and colleagues report on a trial of 59 dogs with treatment naïve lymphoma that were successfully treated with alternating rabacfosadine and doxorubicin. Both drugs demonstrate efficacy against lymphoma and possess different mechanisms of action.